MilliporeSigma Capacity Update July 2025: ADC

With more than 15 years of experience as conjugation and linker-payload CDMO, MilliporeSigma has a proven track record of supporting clinical programs from IND to PPQ for commercialization.

With more than 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions (Simtra) offers world-class GMP sterile fill and finish services, deep scientific and technical expertise, and a uniquely collaborative approach to support our customers’ strategic objectives.

As two industry-leading CDMOs in the ADC field, MilliporeSigma and Simtra have forged a Strategic Alliance for Drug Substance and Drug Product ADC Manufacturing with the shared goal to delivering your drug development program to market more efficiently.

Our streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill-finish of drug substance, enabling us to meet the unique demands of each project.